Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Chemotechnique MB MedPharma AB
AB
Active
Org 5595379073
Economic activity was not specified by tax authority
· NACE 0000
Est. 2025
0 employees
Watchlist
Share
Sweden
/
Companies
/
Economic activity was not specified by tax authority
/
Chemotechnique MB MedPharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
PM
Patric Mathias Andersson
Auditor Substitute
Auditor Substitute
2025
CJ
Carl Jesper Sturesson
Audit
Audit
2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
LM
Lena Marie Niklasson
Board of Directors
2025
JH
Jenny Helena Friman
Board of Directors
2025
BJ
Bo Johan Niklas Niklasson
Chairman
2025
DM
David M N Alsheimer-Niklasson
Board of Directors
2025
Former (15)
JA
Jan Anders Fredrik Lovén
Deputy Board Member
2025 – 2025
JT
Jan Totte Dahlin
Deputy Board Member
2025 – 2025
VE
Viktor Elias Bergman Gullmark
Deputy Board Member
2025 – 2025
EM
Emma Maria Birgitta Wik
Deputy Board Member
2025 – 2025
AH
Andreas Hans Eddie Ottosson
Deputy Board Member
2025 – 2025
LC
Lina Charlotta Öhrnell
Deputy Board Member
2025 – 2025
LA
Lars Anders Larsson
Board of Directors
2025 – 2025
LM
Linn Mikaela Engman
Deputy Board Member
2025 – 2025
AS
Anna Stina Hammarström
Deputy Board Member
2025 – 2025
AM
Aline Madeleine Pettersson
Deputy Board Member
2025 – 2025
EA
Elin Anna Margareta Spjut
Deputy Board Member
2025 – 2025
TA
Tuva Amalia Lundin
Deputy Board Member
2025 – 2025
JL
Jill Liv Maria Jonsson Wik
Deputy Board Member
2025 – 2025
JE
Julia Engla Eva M Arnfridsdotter
Deputy Board Member
2025 – 2025
AK
Anna Klara Alina Bruksås Nybjörk
Deputy Board Member
2025 – 2025
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Chemotechnique MB MedPharma AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network